Literature DB >> 23307823

Airway dimensions in asthma and COPD in high resolution computed tomography: can we see the difference?

Justyna Kosciuch1, Rafal Krenke, Katarzyna Gorska, Malgorzata Zukowska, Marta Maskey-Warzechowska, Ryszarda Chazan.   

Abstract

BACKGROUND: Airway remodeling in asthma and COPD results in bronchial wall thickening. The thickness of the bronchial wall can be measured in high-resolution computed tomography. The objectives of the study were to assess the bronchial lumen and wall dimensions in asthma and COPD patients, in relation to disease severity, and to compare the airway dimensions in patients with asthma and COPD.
METHODS: Ten asthma subjects and 12 COPD subjects with stable, mild to moderate disease were investigated. All subjects underwent chest high-resolution computed tomography (window level - 450 Hounsfield units, window width 1,500 Hounsfield units). Cross-sections of bronchi (external diameter 1.0-5.0 mm) were identified on enlarged images. The following variables were measured: external and internal diameter, wall area, lumen area, total airway area, the percentage of airway wall area, wall thickness, and the ratio of wall thickness to external diameter. Separate sub-analyses were performed for airways with external diameter ≤ 2.0 mm and external diameter > 2.0 mm.
RESULTS: We measured 261 and 348 cross-sections of small airways in subjects with asthma and COPD, respectively. There was a significant difference in wall thickness and wall area, which were both greater in asthmatics than in COPD patients. In bronchi with external diameter > 2.0 mm, all measured parameters were significantly higher in asthma than COPD. In individual asthmatics the airway wall thickness was similar in all the assessed bronchi, while in COPD it was related to the external airway diameter.
CONCLUSIONS: Our results indicate that bronchial walls are thicker in asthmatics than in patients with COPD. It seems that airway wall thickness and the lumen diameter in patients with asthma are related to disease severity. There is no such a relationship in COPD patients. High-resolution computed tomography may be a useful tool in the assessment of airway structure in obstructive lung disease.

Entities:  

Keywords:  COPD; airway remodeling; airway thickness; asthma; high-resolution computed tomography

Mesh:

Year:  2013        PMID: 23307823     DOI: 10.4187/respcare.02175

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  13 in total

1.  Quantitative assessment of multiscale structural and functional alterations in asthmatic populations.

Authors:  Sanghun Choi; Eric A Hoffman; Sally E Wenzel; Mario Castro; Sean B Fain; Nizar N Jarjour; Mark L Schiebler; Kun Chen; Ching-Long Lin
Journal:  J Appl Physiol (1985)       Date:  2015-03-26

Review 2.  Airway and lung remodelling in chronic pulmonary obstructive disease: a role for muscarinic receptor antagonists?

Authors:  Michael Roth
Journal:  Drugs       Date:  2015-01       Impact factor: 9.546

3.  Differentiation of quantitative CT imaging phenotypes in asthma versus COPD.

Authors:  Sanghun Choi; Babak Haghighi; Jiwoong Choi; Eric A Hoffman; Alejandro P Comellas; John D Newell; Sally E Wenzel; Mario Castro; Sean B Fain; Nizar N Jarjour; Mark L Schiebler; R Graham Barr; MeiLan K Han; Eugene R Bleecker; Christopher B Cooper; David Couper; Nadia Hansel; Richard E Kanner; Ella A Kazerooni; Eric A C Kleerup; Fernando J Martinez; Wanda K O'Neal; Prescott G Woodruff; Ching-Long Lin
Journal:  BMJ Open Respir Res       Date:  2017-11-09

4.  Assessment of proximal and peripheral airway dysfunction by computed tomography and respiratory impedance in asthma and COPD patients with fixed airflow obstruction.

Authors:  Prapaporn Pornsuriyasak; Thitiporn Suwatanapongched; Wasana Thaipisuttikul; Chayanin Nitiwarangkul; Theerasuk Kawamatawong; Naparat Amornputtisathaporn; Kittipong Maneechotesuwan
Journal:  Ann Thorac Med       Date:  2018 Oct-Dec       Impact factor: 2.219

5.  In vitro delivery efficiencies of nebulizers for different breathing patterns.

Authors:  Hyun Mok Park; Kyung Hwa Chang; Sang-Hyub Moon; Bong Joo Park; Sun Kook Yoo; Ki Chang Nam
Journal:  Biomed Eng Online       Date:  2021-06-10       Impact factor: 2.819

6.  Relationship between lung function and quantitative computed tomographic parameters of airway remodeling, air trapping, and emphysema in patients with asthma and chronic obstructive pulmonary disease: A single-center study.

Authors:  Ruth A Hartley; Bethan L Barker; Chris Newby; Mini Pakkal; Simonetta Baldi; Radhika Kajekar; Richard Kay; Marie Laurencin; Richard P Marshall; Ana R Sousa; Harsukh Parmar; Salman Siddiqui; Sumit Gupta; Chris E Brightling
Journal:  J Allergy Clin Immunol       Date:  2016-03-19       Impact factor: 10.793

Review 7.  Airflow obstruction: is it asthma or is it COPD?

Authors:  Paola Rogliani; Josuel Ora; Ermanno Puxeddu; Mario Cazzola
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-11-30

8.  Protective effect of autophagy on endoplasmic reticulum stress induced apoptosis of alveolar epithelial cells in rat models of COPD.

Authors:  Yao Tang; Qi-Hang Cai; Yong-Jian Wang; Shao-Hua Fan; Zi-Feng Zhang; Meng-Qi Xiao; Jin-Yu Zhu; Dong-Mei Wu; Jun Lu; Yuan-Lin Zheng
Journal:  Biosci Rep       Date:  2017-11-15       Impact factor: 3.840

9.  Visual and Quantitative Assessments of Regional Xenon-Ventilation Using Dual-Energy CT in Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome: A Comparison with Chronic Obstructive Pulmonary Disease.

Authors:  Hye Jeon Hwang; Sang Min Lee; Joon Beom Seo; Jae Seung Lee; Namkug Kim; Sei Won Lee; Yeon Mok Oh
Journal:  Korean J Radiol       Date:  2020-09       Impact factor: 3.500

10.  Longitudinal changes in structural lung abnormalities using MDCT in chronic obstructive pulmonary disease with asthma-like features.

Authors:  Rie Anazawa; Naoko Kawata; Yukiko Matsuura; Jun Ikari; Yuji Tada; Masaki Suzuki; Shin Takayanagi; Shin Matsuoka; Shoichiro Matsushita; Koichiro Tatsumi
Journal:  PLoS One       Date:  2019-12-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.